866-997-4948(US-Canada Toll Free)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium

Published By :

N/A

Published Date : Apr 2018

Category :

Pharmaceutical

No. of Pages : 131 Pages

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Belgium. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Belgium. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

Belgium is one of the largest healthcare markets, with a strong focus on pharmaceutical exports. It spends approximately 10.4% of its GDP on healthcare. The value of the Belgian pharmaceutical market declined from $7.8 billion in 2009 to $6.9 billion in 2016, at a negative compound annual growth rate (CAGR) of 2%. However, the value of the pharmaceutical market in terms of Euros increased from 5.8 billion to 6.2 billion at a CAGR of 1%. This difference was due to the declining exchange rate of the Euro versus the US Dollar. The Belgian medical device market was valued at $2.16 billion in 2010, which increased to $2.68 billion in 2017. The main segments were cardiovascular devices, ophthalmic devices, orthopedic devices, in vitro diagnostics and hospital supplies. The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of the pharmaceutical market. However, generic substitution and high taxes act as a major barrier for the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Belgium, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Sanofi, Leo Pharma, UCB Pharma and Ablynx) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Essilor, Zimmer Biomet, AGFA and IBA)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Belgium
- Porters five forces analysis for pharmaceutical and medical devices market of Belgium
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Belgian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Belgian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Belgian healthcare market.
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Pharmaceutical Market, Belgium, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2015 21
Table 2: Medical Device Market, Belgium, Revenue by Segment ($m), 2017 41
Table 3: Cardiovascular Devices Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2017 42
Table 4: Ophthalmic Devices Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2015 43
Table 5: Orthopedic Devices Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2016 44
Table 6: IVD Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2016 45
Table 7: Hospital Supplies Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2014 46
Table 8: Types of Reimbursement Claims, Belgium, 2017 80
Table 9: Reimbursement Categories, Belgium, 2017 81
Table 10: Co-payments, Belgium, 2017 82
Table 11: Market Authorization Fees, 2018, Belgium 88
Table 12: Patent Fees, Belgium, 2017 98
Table 13: Provisions for the advertisement of medicines for human use, Belgium, 2017 103
Table 14: Pharmacy Licensing Requirements, Belgium, 2017 104
Table 15: Primary Packaging Labeling Information, Belgium, 2017 105
Table 16: Blister Packaging Labeling Information, Belgium, 2017 105
Table 16: Small Packaging Labeling Information, Belgium, 2017 105
Table 17: Trade Fairs, Belgium, 2017 117

List of Figures
Figure 1: Pharmaceutical Market, Belgium, Revenue ($bn), 2010-2017 8
Figure 2: Medical Device Market, Belgium, Revenue ($bn), 2010-2017 8
Figure 3: Country Profile, Belgium, 2018 14
Figure 4: Pharmaceutical Market, Belgium, Revenue ($bn), 2010-2017 16
Figure 5: Pharmaceutical Market, Belgium, Revenue Forecast ($bn), 2018-2022 16
Figure 6: Pharmaceutical Exports ($bn), Belgium, 2010-2017 17
Figure 7: Top Export Partners, Belgium, 2016 17
Figure 8: Pharmaceutical Imports ($bn), Belgium, 2010-2017 18
Figure 9: Top Import Partners, Belgium, 2016 18
Figure 10: Pharmaceutical Market, Belgium, Major therapeutic groups based on sales ($m), 2015 21
Figure 11: Pharmaceutical Market, Belgium, Major Players 23
Figure 12: Medical Device Market, Belgium, Revenue ($bn), 2010-2017 40
Figure 13: Medical Device Market, Belgium, Revenue Forecast ($bn), 2018-2022 40
Figure 14: Medical Device Market, Belgium, Revenue by Segment ($m), 2017 41
Figure 15: Cardiovascular Devices Market, Belgium, Revenue ($m), 2010-2017 42
Figure 16: Cardiovascular Devices Market, Belgium, Market Share of Major Players (%), 2015 42
Figure 17: Ophthalmic Devices Market, Belgium, Revenue ($m), 2010-2017 43
Figure 18: Ophthalmic Devices Market, Belgium, Market Share of Major Players (%), 2017 43
Figure 19: Orthopedic Devices Market, Belgium, Revenue ($m), 2010-2017 44
Figure 20: Orthopedic Devices Market, Belgium, Market Share of Major Players (%), 2016 44
Figure 21: IVD Market, Belgium, Revenue ($m), 2010-2017 45
Figure 22: IVD Market, Belgium, Market Share of Major Companies (%), 2017 45
Figure 23: Hospital Supplies Market, Belgium, Revenue ($m), 2010-2017 46
Figure 24: Hospital Supplies Market, Belgium, Market Share of Major Companies (%), 2017 46
Figure 25: Diagnostic Market, Belgium, Revenue ($bn), 2010-2017 47
Figure 26: Diagnostic Market, Belgium, Revenue ($bn), 2018-2022 47
Figure 27: Medical Device Market, Belgium, Revenue ($bn) of Major Companies, 2016 49
Figure 28: Deal Value and Deal Count, Pharmaceutical Market, Belgium, 2017-2018 69
Figure 29: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Belgium, 2017-2018 69
Figure 30:Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Belgium, 2017-2018 69
Figure 31: Top 5 therapy area by deal value, Pharmaceutical Market, Belgium, 2017-2018 70
Figure 32: Top 5 therapy area by deal number, Pharmaceutical Market, Belgium, 2017-2018 70
Figure 33: VF deals by therapy area, Pharmaceutical Market, Belgium, 2017-2018 (By value and by number) 70
Figure 34: M&A deals by therapy area, Pharmaceutical Market, Belgium, 2017-2018 (By value and by number) 70
Figure 35: PE deals by therapy area, Pharmaceutical Market Belgium, 2017-2018 (By value and by number) 70
Figure 36:Medical Device Market Deals (by deal value, $m), Belgium, 2017-2018 71
Figure 37:Medical Device Market Deals (by deal count), Belgium, 2017-2018 71
Figure 38: Medical Device Market Deals Share (by deal count), Belgium, 2017-2018 71
Figure 39: Medical Device Market Deals Share (by deal value), Belgium, 2017-2018 71
Figure 40: Medical Device, Belgium, Top Therapy Area by Deal Value, 2017-2018 72
Figure 41: Medical Devices, Belgium, Top Therapy Area by Deal Number, 2017-2018 72
Figure 42: Medical Devices, Belgium, M&A Deals by Therapy Area, 2017-2018 72
Figure 43: Medical Devices, Belgium, VF Deals by Therapy Area, 2017-2018 72
Figure 44: Medical Devices, Belgium, PE Deals by Therapy Area, 2017-2018 72
Figure 45: NIHDI Organization Structure, Belgium, 2015 77
Figure 46: Reimbursement Process, Belgium, 2017 79
Figure 47: Out-of-Pocket Expenditure (% of total expenditure on health), Belgium, 2010-2017 83
Figure 48: Annual Rate of Change (%), Health Price Index, Belgium, 2010-2017 83
Figure 49: Federal Agency for Medicines and Health Products, Organization Chart, Belgium, 2017 87
Figure 50: Centralized Procedure, Belgium, 2017 89
Figure 51: Decentralized Procedure, Belgium, 2017 90
Figure 52: Mutual Recognition Procedure, Belgium, 2017 91
Figure 53: Conformity Assessment of Class I Medical Devices, EU, 2017 93
Figure 54: Conformity Assessment of Class IIa Medical Devices, EU, 2017 94
Figure 55: Conformity Assessment of Class IIb Medical Devices, EU, 2017 95
Figure 56: Conformity Assessment of Class III Medical Devices, EU, 2017 96
Figure 57: European Patent Approval Process, EU, 2017 99
Figure 58: Unitary Patent Approval Process, EU, 2017 100
Figure 59: Trademark Approval Process, Belgium, 2018 101
Figure 60: Clinical Trial Approval Process, Belgium, 2017 102
Figure 61: Number of Hospitals, Belgium, 2010-2017 108
Figure 62: Diagnostic Equipment (per million population), Belgium,2010-2017 108
Figure 63: Hospital Beds (per 100,000 population), Belgium, 2010-2017 109
Figure 64: Curative Care Hospital Beds (per 100,000 population), Belgium, 2010-2017 109
Figure 65: Psychiatric Hospital Beds (per 100,000 population), Belgium, 2010-2017 109
Figure 66: Life Expectancy, Belgium, 2010-2017 110
Figure 67: Immunization Rate (%), Belgium, 2010-2017 110
Figure 68: PM2.5 (g per m3), Belgium, 2010-2017 111
Figure 69: CO2 Emissions (million tons), Belgium, 2010-2017 111
Figure 70: Physicians (per 1,000 population), Belgium, 2010-2017 112
Figure 71: Dentists (per 1,000 population), Belgium, 2010-2017 112
Figure 72: Nurses (per 1,000 population), Belgium, 2010-2017 112
Figure 73: Pharmacists (per 1,000 population), Belgium, 2010-2017 112
Figure 74: Major Causes of Mortality (number of deaths), Belgium, 2014 113
Figure 75: Major Causes of Male Mortality (number of deaths), Belgium, 2014 113
Figure 76: Major Causes of Female Mortality (number of deaths), Belgium, 2014 113
Figure 77: Disability-Adjusted Life Years by Major Disease (000), Belgium, 2015 113
Figure 78: Healthcare Expenditure as Percentage of GDP (%), Belgium, 2010-2017 114
Figure 79: Public-Private Share (%), Belgium, 2010-2017 114
Figure 80: Major Components of Healthcare Spending (%), Belgium, 2015 115
Figure 81:Spending in Pharmaceutical and Healthcare R&D ($bn), Belgium, 2010-2015 115
Figure 82: Opportunities and Challenges 119

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *